YA Wang, EA Sullivan, S Abeywardana… - Human …, 2011 - ESHRE 0.71-0.96 respectively), cycles in donors aged 40 years or older had 42% and 54% less chance to achieve a pregnancy and a live delivery (ARR 0.58 with 95% CI 0.41-0.84, ARR 0.46 with 95% CI 0.29-0.73 respectively). Similarly of embryo transfer cycles, there were no ...
D Hashimoto, A Chow, M Greter… - The Journal of …, 2011 - jem.rupress.org Acute graft-versus-host disease (GVHD) results from the attack of host tissues by donor allogeneic T cells and is the most serious limitation of allogeneic hematopoietic cell transplantation (allo-HCT). Host antigen-presenting cells are thought to control the priming of alloreactive ... Related articles - All 3 versions
[PDF] from britjtransplant.comVC Emery - Supplement Overview, 2011 - britjtransplant.com February 2011 17 Cytomegalovirus Vaccines: The Past, Present and Future and Their Role in Protecting the Transplant Recipient by Prof Vincent C Emery Professor of Virology Department of Infection (Royal Free Campus) University College Medical School Rowland Hill Street, ... Related articles - View as HTML
D Gross… - US Patent 7,941,496, 2011 - Google Patents Illllllllllllllllllllllllllllllllllllllllllllllli US007941496B2 (12) United States Patent ao) Patent no.: us 7,941,496 B2 Gross et al. (45) Date of Patent: May 10,2011 (54) SYSTEM, METHOD AND COMPUTER PROGRAM FOR RECIPIENT CONTROLLED COMMUNICATIONS (76) Inventors: Daniel ... Related articles - All 4 versions
P Tryphonopoulos, D Weppler, MI Morris… - …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ...
YA Wang, EA Sullivan, S Abeywardana… - Human …, 2011 - ESHRE 0.71-0.96 respectively), cycles in donors aged 40 years or older had 42% and 54% less chance to achieve a pregnancy and a live delivery (ARR 0.58 with 95% CI 0.41-0.84, ARR 0.46 with 95% CI 0.29-0.73 respectively). Similarly of embryo transfer cycles, there were no ...
D Hashimoto, A Chow, M Greter… - The Journal of …, 2011 - jem.rupress.org Acute graft-versus-host disease (GVHD) results from the attack of host tissues by donor allogeneic T cells and is the most serious limitation of allogeneic hematopoietic cell transplantation (allo-HCT). Host antigen-presenting cells are thought to control the priming of alloreactive ... Related articles - All 3 versions
[PDF] from britjtransplant.comVC Emery - Supplement Overview, 2011 - britjtransplant.com February 2011 17 Cytomegalovirus Vaccines: The Past, Present and Future and Their Role in Protecting the Transplant Recipient by Prof Vincent C Emery Professor of Virology Department of Infection (Royal Free Campus) University College Medical School Rowland Hill Street, ... Related articles - View as HTML
D Gross… - US Patent 7,941,496, 2011 - Google Patents Illllllllllllllllllllllllllllllllllllllllllllllli US007941496B2 (12) United States Patent ao) Patent no.: us 7,941,496 B2 Gross et al. (45) Date of Patent: May 10,2011 (54) SYSTEM, METHOD AND COMPUTER PROGRAM FOR RECIPIENT CONTROLLED COMMUNICATIONS (76) Inventors: Daniel ... Related articles - All 4 versions
P Tryphonopoulos, D Weppler, MI Morris… - …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ...